Directors
Directors
6 directors, 3 in day-to-day management, last change in 2026
Board 6
Bernard Heintz
Current
Director · since 19-12-2023 · 6-year term from 2026 · listed in the 2025 annual accounts, filed on 30-06-2026
MOVENDIS
Current
Director · since 19-12-2023 · 6-year term from 2026 · Private limited company · permanent representative: Kathleen Moons · also on the board of 1 other company · listed in the 2025 annual accounts, filed on 30-06-2026
Nicholas Coton
Current
Director · appointed by deed of 04-03-2026 · 6-year term from 2026
Guilia Mazza
Current
Director · appointed by deed of 04-11-2026 · 6-year term from 2026
Peter Byloos
Current
Director · appointed by deed of 04-11-2026
Lode Vlaminck
Current
Director · appointed by deed of 04-11-2026 · 6-year term from 2026
Day-to-day management 3
MERTENS Erik Louis Juliaan Ghislain
Current
Managing director · appointed by deed of 23-01-2024 · earlier director, from 19-12-2023 to 23-01-2024
MOVENDIS
Current
Managing director · appointed by deed of 04-03-2026 · Private limited company · permanent representative: Kathleen Moons
Merel Venneman
Current
Day-to-day manager · appointed by deed of 04-11-2026 · 6-year term from 2026
Permanent representatives 1
Kathleen Moons
Current
Permanent representative · appointed by deed of 23-01-2024 · for MOVENDIS
Signing authorityThe articles say who may bind the company, for example by signing a contract.
“De raad van bestuur en de gedelegeerden tot het dagelijks bestuur, deze laatsten binnen de grenzen van dit bestuur, mogen bijzondere machten…”
deed of 09-02-2026Owners and capital
Shareholders
1 ownerChain of control
- Signifeye
- EQIRIS
Owners 1
- SignifeyeparentSourceaccounts Signifeye 2025Equity €14.2m Profit of €6.0m in 2025 (profit of €752,865 in 2024) Checked score 99100%
Capital transactions
Capital over time
- 09-02-2026 Capital stated in 2 deeds · €8,290,000 · 13,345,000 shares
- 26-10-2022 Capital increase of €1,065,000 · to €8,290,000 · 1,065,000 new shares · in cash
- 06-01-2022 Capital increase of €1,100,000 · to €7,225,000 · 1,100,000 new shares · in cash
Mandate history
27 people, 8 in office
- Board
- Day-to-day management
- mandate already running before its first mention
- end not dated
| Name | Functions and periods |
|---|---|
| Bernard Heintz |
|
| Nicholas Coton |
|
| Guilia Mazza |
|
| Peter Byloos |
|
| Lode Vlaminck |
|
| MERTENS Erik Louis Juliaan Ghislain |
|
| MOVENDIS |
|
| Merel Venneman |
|
| Nicolas Coton |
|
| Ann Haustermans |
|
| Erik Mertens |
|
| Fernand De Wilde |
|
| Frank Kesteloot |
|
| Huib Lodewijks |
|
| Maria Dieltiëns |
|
| MED.OPHTA |
|
| Signifeye |
|
| VRYGHEM Jérôme |
|
| DE WILDE Fernand André Marie |
|
| DIELTIËNS Maria Anna |
|
| HEINTZ Bernard Emmanuel |
|
| ILAT |
|
| Kathleen Moons |
|
| KESTELOOT Frank Jozef Alexander |
|
| NIJS Ivo Elisa Godfried |
|
| Prime Management BV |
|
| DONK INVEST |
|
Articles of association
Board and representation
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 3 directors“Alle handelingen nodig of dienstig tot verwezenlijking voorwerp, niet strijdig met artikelen Code Medische Deontologie”
deed of 09-02-2026 (in Dutch)
Capital, shares and profit
- Kind of sharesThe articles set which classes of shares exist and what rights each class carries.
- “Tenzij uitdrukkelijk anders bepaald in statuten of Aandeelhoudersovereenkomst, soort reeds gehouden door overnemende Aandeelhouder”
deed of 26-10-2022 (in Dutch)
Audit, dissolution and liquidation
- Liquidation ruleIn a liquidation the creditors are paid first. What is left goes to the shareholders.
- “Algemene vergadering bepaalt wijze vereffening overeenkomstig wettelijke bepalingen bij ontbinding, beroep op artsen voor zaken persoonlijke…”
deed of 09-02-2026 (in Dutch)